Hyperlipidemias: Clinical Trials

168 trials for Hyperlipidemias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

168 completed. 168 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4168Completed 168

Follow Hyperlipidemias: new trials by email Literature Review of Hyperlipidemias trials Research Report on Hyperlipidemias

Trials (filtered) newest first · largest first

All 168 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol
Rosuvastatin + Ezetimibe, Bempedoic Acid + Ezetimibe, Rosuvastatin + Ezetimibe + Bempedoic Acid - Type 2 Diabetes Mellitus, Hypercholesterolemia / Elevated LDL Cholesterol
Phase 4CompletedBahria University1262026-01-012026-10-20
A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan
Bempedoic acid 180 mg tablet - Primary Hypercholesterolemia or Mixed Hyperlipidemia
Phase 4CompletedDaiichi Sankyo1802025-04-012025-12-08
A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.
Inclisiran sodium, BPA - Hypercholesterolemia
Phase 4CompletedNovartis Pharmaceuticals4022024-06-212026-07-29
EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)
moderate- or high-intensity statin/ rosuvastatin - Lipid Disorder
Phase 4CompletedWake Forest University Health Sciences222023-03-082026-10-02
Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia
Inclisiran Sodium, Placebo - Hypercholesterolemia
Phase 4CompletedNovartis Pharmaceuticals17702022-04-082026-04-14
Lipid Management in Renal Transplant Recipients Using Evolocumab.
Evolocumab - Hyperlipidemias
Phase 4CompletedBrigham and Women's Hospital812021-02-172026-04-16
The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk
Icosapent Ethyl 1000 MG Oral Capsule [Vascepa] - Cardiovascular Diseases, Cardiovascular Risk Factor
Phase 4CompletedCanadian Medical and Surgical Knowledge Translation Research Group702020-09-242024-04-02
Effect of Pitavastatin on Bone
Pitavastatin - Osteoporosis, Osteopenia, Hypercholesterolemia
Phase 4CompletedSeoul National University Bundang Hospital702019-04-082024-04-11
Effect of Red Yeast Rice Beside Statin on Lipid Profile
Red Yeast Rice Pill, Placebo - Hyperlipidemias
Phase 4CompletedShiraz University of Medical Sciences922019-03-012021-10-27
Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia
Evolocumab - Hypercholesterolemia, Familial
Phase 4CompletedInstituto de Seguridad y Servicios Sociales de los Trabajadores del Estado202019-01-012024-01-30
Safety and Tolerability of Repatha® (Evolocumab) in Indian Participants With Homozygous Familial Hypercholesterolemia
evolocumab - Homozygous Familial Hypercholesterolemia HoFH
Phase 4CompletedAmgen302018-08-042024-05-29
Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets
Ezetimibe/Rosuvastatin, Candesartan cilexetil/Amlodipine besylate, Candesartan cilexetil - Hypertension, Hyperlipidemia
Phase 4CompletedHK inno.N Corporation1272018-07-052022-05-10
Alirocumab and Plaque Burden In Familial Hypercholesterolaemia
Alirocumab - Familial Hypercholesterolemia
Phase 4CompletedFundación Hipercolesterolemia Familiar1042018-05-012022-07-19
Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia
Rosuvamibe® Tab, Monorova® Tab - Type 2 Diabetes Mellitus, Hypercholesterolemia
Phase 4CompletedYuhan Corporation1402018-02-232019-07-23
Impact of Statin Therapy on Adaptations to Aerobic Exercise
Lipitor 20Mg Tablet, Lipitor 80Mg Tablet, Placebo - Cardiovascular Diseases
Phase 4CompletedUniversity of Kansas Medical Center522018-02-012025-04-15
Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg
Lipilou®(generic atorvastatin drug) 20 mg, Lipilou®(generic atorvastatin drug) 10 mg - Hypercholesterolemia
Phase 4CompletedChong Kun Dang Pharmaceutical2502017-10-112020-08-12
A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia
Rosuvastatin+Ezetimibe, Rosuvastatin - Diabetes Mellitus and Hypercholesterolemia
Phase 4CompletedYuhan Corporation852017-08-102019-09-23
Lipid-lowering Therapy Individualization
Atorvastatin - Hypercholesterolemia
Phase 4CompletedUniversité Catholique de Louvain752017-08-082019-09-03
Evaluation of the Effect of a Shiitake Extract on Lipid Profile in Subjects With Moderate Hyperlipidemia
Experimental product, Placebo product - Hypercholesterolemia, Hyperlipidemias
Phase 4CompletedInstituto de Investigación Hospital Universitario La Paz572017-05-082022-01-13
The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)
Omega-3 fatty acid, Placebos - Type 2 Diabetes Mellitus, Hypertriglyceridemia
Phase 4CompletedShanghai Jiao Tong University School of Medicine3092017-05-012023-10-30

Showing 20 of 168. Sign in to see all of them.

Narrower conditions

Hypercholesterolemia (109)  ·  Hypertriglyceridemia (20)  ·  Cardiovascular Diseases (17)  ·  Dyslipidemias (17)  ·  Insulin Resistance (12)  ·  Hypertension (11)  ·  Diabetes Mellitus, Type 2 (10)  ·  Hyperlipoproteinemia Type II (10)  ·  Atherosclerosis (9)  ·  Coronary Disease (9)  ·  Diabetes Mellitus (9)  ·  Coronary Artery Disease (8)  ·  HIV Infections (6)  ·  Inflammation (4)

Broader conditions

Nutritional and Metabolic Diseases (168)  ·  Metabolic Diseases (167)  ·  Lipid Metabolism Disorders (164)  ·  Dyslipidemias (151)  ·  Vascular Diseases (42)  ·  Cardiovascular Diseases (35)  ·  Glucose Metabolism Disorders (31)  ·  Myocardial Ischemia (21)  ·  Heart Diseases (20)  ·  Arterial Occlusive Diseases (19)  ·  Arteriosclerosis (19)  ·  Endocrine System Diseases (19)  ·  Hyperinsulinism (15)  ·  Pathological Conditions, Signs and Symptoms (12)

Interventions

Atorvastatin (37)  ·  Ezetimibe (28)  ·  Rosuvastatin Calcium (19)  ·  Simvastatin (19)  ·  Fenofibrate (10)  ·  Ezetimibe, Simvastatin Drug Combination (9)  ·  Colesevelam Hydrochloride (8)  ·  Omacor (8)  ·  Pravastatin (8)  ·  pitavastatin (8)  ·  Hydroxymethylglutaryl-CoA Reductase Inhibitors (7)  ·  Amlodipine (6)  ·  Niacin (5)  ·  alirocumab (4)  ·  evolocumab (3)

Sponsors

Organon and Co (16)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (11)  ·  Gachon University Gil Medical Center (9)  ·  Daiichi Sankyo (7)  ·  Seoul National University Hospital (4)  ·  Yonsei University (4)  ·  AstraZeneca (3)  ·  JW Pharmaceutical (3)  ·  GlaxoSmithKline (2)  ·  Kumamoto University (2)  ·  Novartis Pharmaceuticals (2)  ·  Radiant Research (2)  ·  Takeda (2)  ·  UCSF Benioff Children's Hospital Oakland (2)  ·  University Hospital Freiburg (2)

Countries

United States (44)  ·  South Korea (27)  ·  Japan (11)  ·  Canada (7)  ·  France (7)  ·  Germany (6)  ·  Spain (6)  ·  China (5)  ·  Mexico (5)  ·  Taiwan (5)  ·  Poland (4)  ·  Austria (3)  ·  Belgium (3)  ·  Czechia (3)  ·  Greece (3)

Top investigators

Ronald M Krauss, M.D. (2)  ·  Aaron I Vinik, MD, PhD (1)  ·  Adrian S Dobs, MD (1)  ·  Alex Laursen, D.M., DMSc (1)  ·  Alicja E. Grzegorzewska, MD, PhD (1)  ·  Ana Polanco, MD (1)  ·  Andreas Hahn, Prof. (1)  ·  Andrew D Carr, MD (1)  ·  Anh Le, PhD (1)

Results publications

PMID 10323786, PMID 10593347, PMID 11009277, PMID 11558482, PMID 11781675, PMID 11849859, PMID 12379573, PMID 12652104, PMID 16404415, PMID 16749654, PMID 16893434, PMID 16923260, PMID 17011942, PMID 17407633, PMID 17578790, PMID 17668878, PMID 17711927, PMID 18172039, PMID 18332269, PMID 18398080, PMID 18404599, PMID 18545068, PMID 18559695, PMID 18762410, PMID 19060422, PMID 19095139, PMID 19104004, PMID 19116237, PMID 19167589, PMID 19286582, PMID 19407658, PMID 19423108, PMID 19597368, PMID 19608026, PMID 19651918, PMID 19820283, PMID 19879596, PMID 19939653, PMID 19967051, PMID 20067513, PMID 20298928, PMID 20339536, PMID 20413733, PMID 20467151, PMID 20617456, PMID 20663203, PMID 20684825, PMID 20888102, PMID 21062616, PMID 21122660

NIH funding

2004 (1), 2005 (1), 2015 (1), 2016 (1), K23AT002862 (1), K23HL169929 (1), R01AR071263 (1), R01DK061486 (1), R01HL075824 (1), R01MH071536 (1)